CD31/PECAM-1 Products

Description

Cluster of differentiation (CD31), Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1), is a 30kDa type I transmembrane glycoprotein expressed by endothelial cells, platelets, leukocytes and some lymphocytes (e.g., B and T-cell subsets). Structurally, PECAM-1 consists of six extracellular immunoglobulin-like domains which serve to support various functions including homophilic binding, maintaining high expression of PECAM-1 within endothelial intercellular junctions, and supporting endothelial cell migration (1,2). PECAM's homophilic binding underscores its role in vascular barrier integrity and leukocyte trans-endothelial movement. However, PECAM may also engage in heterophilic interactions with molecules such as glycosaminoglycans (GAG), integrin alpha 5 beta 3, CD38 in lymphocytes and CD177/PR3 in neutrophils (2).

PECAM's intracellular cytoplasmic domain consists of a sequence of 118 amino acids and contains serine and tyrosine (also referred to as immunoreceptor tyrosine-based inhibitory motifs-ITIMs) residues, which may be phosphorylated upon cellular stimulation (3). ITIMs are phosphorylated by Src-family kinases and non-Src family kinases (e.g., Csk), leading to a conformational change which supports interactions with Src homology 2 (SH2) domain containing proteins such as protein-tyrosine phosphatase, SHP-2 (1,2). Formation of SHP-2/PECAM-1 complexes induces endothelial cell migration through the dephosphorylation of focal adhesion kinase and regulation of RhoA activity (1). Signaling downstream of ITIM tyrosine phosphorylations also plays a role in PECAM's anti-apoptotic activity, a function which is independent of its interaction with SHP-2. In platelets and leukocytes, phosphorylation of PECAM's cytosolic domain is inhibitory, preventing their activation.

References

1. Lertkiatmongkol, P., Liao, D., Mei, H., Hu, Y., & Newman, P. J. (2016). Endothelial functions of PECAM-1 (CD31). Current Opinion in Hematology. https://doi.org/10.1097/MOH.0000000000000239.Endothelial

2. Privratsky, J. R., & Newman, P. J. (2014). PECAM-1: Regulator of endothelial junctional integrity. Cell and Tissue Research. https://doi.org/10.1007/s00441-013-1779-3

3. Newman, P. J., & Newman, D. K. (2003). Signal transduction pathways mediated by PECAM-1: New roles for an old molecule in platelet and vascular cell biology. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.ATV.0000071347.69358.D9

Bioinformatics

Entrez	18316 Mouse 18613 Mouse 29583 Rat 396941 Porcine 5175 Human
Uniprot	AAH22512 Human AAH51822.1 Human NP_000433 Human P16284 Human Q08481 Mouse Q3SWT0 Rat Q95242 Porcine
Product By Gene ID	5175
Alternate Names	adhesion molecule CD31 antigen CD31 CD31/EndoCAM EndoCAM endoCAM FLJ34100 FLJ58394 GPIIA' PECA1 PECAM-1 PECAM-1, CD31/EndoCAM platelet endothelial cell adhesion molecule platelet endothelial cell adhesion molecule-1 platelet/endothelial cell adhesion molecule

Research Areas for CD31/PECAM-1

Find related products by research area and learn more about each of the different research areas below.

Angiogenesis
Cancer
CD Markers
Cellular Markers
Cytoskeleton Markers
Embryonic Stem Cell Markers
Endothelial Cell Markers
Extracellular Matrix
Hematopoietic Stem Cell Markers
Immunology
Mesenchymal Stem Cell Markers
Myeloid Cell Markers
Signal Transduction
Stem Cell Markers

Related CD31/PECAM-1 Blog Posts

Check out the latest blog posts on CD31/PECAM-1.

The application of CD31/Pecam-1 (MEC 7.46) in breast cancer research CD31/PECAM-1, or platelet endothelial cell adhesion molecule 1, is a 130-kDa glycoprotein expressed on vascular and hematopoietic cells.  Depending on the cell type, CD31/PECAM-1 expression can be largely localized to cell junctions, playing a rol...    Read more.

Read more.

Read more CD31/PECAM-1 related blogs.